×

Eli Lilly may react strongly to Alzheimer's drug trial

4:52 PM ET Tue, 22 Nov 2016

CNBC's Meg Tirrell reports on Eli Lilly's Alzheimer's drug trial plans and speaks to incoming CEO David Ricks.